ADARx Pharmaceuticals SEC Filings
NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.79-1.37 (-9.68%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ADARx Pharmaceuticals filing overview
This page lists 23 recent SEC filings by ADARx Pharmaceuticals (ADRX), including 11 4, 3 SCHEDULE 13G, 2 8-K, 2 SCHEDULE 13D. The most recent quarterly report (10-Q) was filed on Nov 12, 2026. The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Nov 12, 2026.
Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
ADRX SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G | Beneficial ownership report (passive) | View on EDGAR |
| Nov 12, 2026 | 8-K | Results of Operations and Financial Condition; Regulation FD Disclosure | View on EDGAR |
| Nov 12, 2026 | 10-Q | Quarterly report | View on EDGAR |
| Oct 16, 2026 | SCHEDULE 13G | Beneficial ownership report (passive) | View on EDGAR |
| Oct 5, 2026 | SCHEDULE 13D | Beneficial ownership report (activist) | View on EDGAR |
| Oct 2, 2026 | SCHEDULE 13D | Beneficial ownership report (activist) | View on EDGAR |
| Oct 1, 2026 | SCHEDULE 13G | Beneficial ownership report (passive) | View on EDGAR |
| Sep 30, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 30, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 30, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 29, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 29, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 29, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 28, 2026 | 424B4 | Prospectus | View on EDGAR |
| Sep 28, 2026 | 8-K | Unregistered Sales of Equity Securities; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Other Events | View on EDGAR |
| Sep 28, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 28, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 28, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 28, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 28, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 21, 2026 | S-1/A | Registration statement (amendment) | View on EDGAR |
| Sep 14, 2026 | S-1/A | Registration statement (amendment) | View on EDGAR |
| Sep 4, 2026 | S-1 | Registration statement | View on EDGAR |